Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEOPA for Better ROM After Multilevel Surgery in Children With Cerebral Palsy
NCT00632528Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2008
- Primary completion
- Mar 2011
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of nitrous oxide + oxygen in cerebral palsy (CP) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Knee range of motion at 7 days. Started Mar 2008; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT00632528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632528.